Approvals/CIMA-AEMPS/NIAPELF 100 MG +150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG

Approved

STANDARD

NIAPELF 100 MG +150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG

Neuraxpharm Pharmaceuticals S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 000367b1cfab24c3
Drug Cima Aemps Name: NIAPELF 100 MG +150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number: 1241795006
Holder Company Name: Neuraxpharm Pharmaceuticals S.L.
Marketing Company Name: Neuraxpharm Spain S.L.
Holder Company Detail Path: /organization/neuraxpharm-pharmaceuticals-s-l
Authorization Date: 2024-04-19
Dosage Form: SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose: 100 mg /150 mg
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Neuraxpharm Pharmaceuticals S.L.
Company Detail Path: /organization/neuraxpharm-pharmaceuticals-s-l

PALIPERIDONA PALMITATO

234 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 19, 2024

Approval ID

000367b1cfab24c3

Type

Standard